Instill Science

A place to discuss science, share work, and find mentors and collaborators

Instill Science / post-3L8fcSAW
January 13, 2023jan-zheng

The Antibacterial Resistance Leadership Group will begin a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial to examine safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa.
Phage Therapy Clinical trial Cystic fibrosis
Loading ...
michael-snider ∙ January 11, 2024 ∙ Edited January 11, 2024